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Cochrane Eyes and Vision: 
systematic reviews 
on myopia
Systematic reviews offer high quality, 
evidence-based guidance to health 
professionals. These reviews address 
myopia and its complications.
Cochrane Eyes and Vision (CEV) is an international network of individuals working to prepare, maintain and promote access to systematic 
reviews of interventions to treat or prevent eye 
diseases or visual impairment, and reviews of the 
accuracy of diagnostic tests. Systematic reviews  are 
summaries of the best available evidence and are 
designed to answer a specific research question. The 
reviews featured here are published in the Cochrane 
Library, which is available free of charge in low- and 
middle-income countries via the Hinari Programme. 
www.who.int/hinari
1 Interventions to slow progression of myopia 
in children
www.cochranelibrary.com/cdsr/
doi/10.1002/14651858.CD004916.pub3
Date: December 2011. Update due in 2019.
Key findings: Anti-muscarinic topical medication slows 
the progression of myopia in children. Adverse effects 
include light sensitivity and near blur. 
2 Vision screening for correctible visual acuity 
deficits in school-age children and adolescents 
www.cochranelibrary.com/cdsr/
doi/10.1002/14651858.CD005023.pub3
Date: February 2018
Key findings: Vision screening plus provision of free 
spectacles improves the number of children who have 
and wear the spectacles they need compared with 
providing a prescription only.
3 Laser photocoagulation for choroidal 
neovascularisation in pathologic myopia
www.cochranelibrary.com/cdsr/
doi/10.1002/14651858.CD004765.pub2/
Date: March 2007
Key findings: The effect of laser photocoagulation 
to treat choroidal neovascularisation due to myopia 
is uncertain.  Adverse effects include enlargement 
of the atrophic laser scar which is potentially vision 
threatening. 
4 Anti-vascular endothelial growth factor for 
choroidal neovascularisation in people with 
pathological myopia
www.cochranelibrary.com/cdsr/
doi/10.1002/14651858.CD011160.pub2
Date: December 2016
Key findings: Low and moderate-certainty evidence 
that people receiving anti-vascular endothelial growth 
factor have a better outcome in terms of visual acuity 
compared with no treatment, photodynamic therapy or 
laser. Adverse effects occurred rarely.
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Providing free spectacles improves the number of 
children who have and wear their spectacles. PAKISTAN
